MADRIGAL PHARMACEUTICALS INC C Virtus ETF Advisers LLC holding in Form 13-F
MDGL
Nasdaq
Virtus ETF Advisers LLC reported holding of MDGL
Virtus ETF Advisers LLC reported holding of MDGL
This chart displays the historical ownership data of MDGL by Virtus ETF Advisers LLC. At the end of Q4 2017 the holding was valued at $402,000.
| Date | Holding Value |
|---|---|
| 402000 | |
| 1125000 | |
| 755000 | |
| 338000 | |
| 304000 | |
| 0 | |
| 288000 | |
| 224000 | |
| 385000 | |
| 246000 | |
| 372000 | |
| 342000 | |
| 272000 | |
| 290000 | |
| 202000 | |
| 158000 | |
| 192000 | |
| 210000 | |
| 0 | |
| 99000 | |
| 696310 | |
| 419837 | |
| 97944 | |
| 56664 | |
| 91858 | |
| 98271 | |
| 333110 | |
| 252330 | |
| 356707 | |
| 0 |
Virtus ETF Advisers LLC reported holdings of MDGL from Q4 2017 to Q1 2025
Historical holdings data showing quarterly positions, market values, shares held, and portfolio percentages for MDGL held by Virtus ETF Advisers LLC from Q4 2017 to Q1 2025
FilingExplorer.com
https://creativecommons.org/licenses/by/4.0/
| Reporting period | Holding Type | Market Value | % of portfolio | Shares | Change in shares | % Change in shares | Qtr end price |
|---|---|---|---|---|---|---|---|
| Q4 2017 | Stock | $402,000 | 0.5% | 4,382 | 4,382 | 0 | $91.79 |
| Q1 2018 | Stock | $1,125,000 | 0.98% | 9,629 | 5,247 | 119.74% | $116.79 |
| Q2 2018 | Stock | $755,000 | 0.67% | 2,699 | -6,930 | -71.97% | $279.69 |
| Q3 2018 | Stock | $338,000 | 0.03% | 1,578 | -1,121 | -41.53% | $214.13 |
| Q4 2018 | Stock | $304,000 | 0.05% | 2,700 | 1,122 | 71.1% | $112.72 |
| Q1 2019 | Stock | $0 | 0 | 0 | -2,700 | -100.0% | - |
| Q2 2019 | Stock | $288,000 | 0.06% | 2,744 | 2,744 | 0 | $104.81 |
| Q3 2019 | Stock | $224,000 | 0.05% | 2,600 | -144 | -5.25% | $86.22 |
| Q4 2019 | Stock | $385,000 | 0.06% | 4,226 | 1,626 | 62.54% | $91.11 |
| Q1 2020 | Stock | $246,000 | 0.1% | 3,683 | -543 | -12.85% | $66.76 |
| Q2 2020 | Stock | $372,000 | 0.18% | 3,287 | -396 | -10.75% | $113.25 |
| Q3 2020 | Stock | $342,000 | 0.18% | 2,879 | -408 | -12.41% | $118.73 |
| Q4 2020 | Stock | $272,000 | 0.11% | 2,444 | -435 | -15.11% | $111.17 |
| Q1 2021 | Stock | $290,000 | 0.12% | 2,480 | 36 | 1.47% | $116.97 |
| Q2 2021 | Stock | $202,000 | 0.08% | 2,078 | -402 | -16.21% | $97.41 |
| Q3 2021 | Stock | $158,000 | 0.07% | 1,976 | -102 | -4.91% | $79.79 |
| Q4 2021 | Stock | $192,000 | 0.07% | 2,270 | 294 | 14.88% | $84.74 |
| Q1 2022 | Stock | $210,000 | 0.09% | 2,139 | -131 | -5.77% | $98.12 |
| Q2 2022 | Stock | $0 | 0 | 0 | -2,139 | -100.0% | - |
| Q3 2022 | Stock | $99,000 | 0.04% | 1,519 | -620 | -28.99% | $64.99 |
| Q4 2022 | Stock | $696,310 | 0.36% | 2,399 | 880 | 57.93% | $290.25 |
| Q1 2023 | Stock | $419,837 | 0.23% | 1,733 | -666 | -27.76% | $242.26 |
| Q2 2023 | Stock | $97,944 | 0.06% | 424 | -1,309 | -75.53% | $231.00 |
| Q3 2023 | Stock | $56,664 | 0.03% | 388 | -36 | -8.49% | $146.04 |
| Q4 2023 | Stock | $91,858 | 0.06% | 397 | 9 | 2.32% | $231.38 |
| Q1 2024 | Stock | $98,271 | 0.05% | 368 | -29 | -7.3% | $267.04 |
| Q2 2024 | Stock | $333,110 | 0.16% | 1,189 | 821 | 223.1% | $280.16 |
| Q3 2024 | Stock | $252,330 | 0.12% | 1,189 | 0 | 0 | $212.22 |
| Q4 2024 | Stock | $356,707 | 0.15% | 1,156 | -33 | -2.78% | $308.57 |
| Q1 2025 | Stock | $0 | 0 | 0 | -1,156 | -100.0% | - |